International Biotechnology Law and Policy

Hunton Andrews Kurth LLP has experience representing international biotechnology companies from both a regulatory and an intellectual property perspective. From a regulatory standpoint, the firm provides a broad range of focused legal and regulatory counseling to companies of all sizes. Hunton Andrews Kurth regulatory lawyers have diverse and complementary backgrounds that include experience and academic degrees in science, business, public policy and government relations. The firm serves clients by providing practical advice effectively and efficiently, by marshaling the appropriate resources to fulfill the client’s business objectives, whether those objectives involve navigating a complex regulatory path, negotiating a major transaction, developing a marketing strategy, responding to an enforcement action or litigating with a competitor. The firm also has knowledge in intellectual property matters specific to biotechnology companies, including patent preparation and prosecution, post-grant proceedings, patent opinion work and litigation. Numerous members of the firm’s intellectual property section hold advanced degrees in biotechnology, chemical engineering and related fields, and focus their practices on work for biotech companies. Included in that group are several who have completed graduate-level work in the area. Members of the team have a range of experience in the biotech industry, some with as much as 30 years.